High ALK gene copy number as a predictor of response to crizotinib in non-small cell lung cancer cell lines

被引：0
|
作者：
Kalai, Khadija [1 ]
Planchard, David [1 ]
Auger, Nathalie [1 ]
Commo, Frederic [1 ]
Dorvault, Nicolas [1 ]
Friboulet, Luc [1 ]
Lacroix, Ludovic [1 ]
Olaussen, Ken [1 ]
Valent, Alexander [1 ]
Soria, Jean Charles [1 ]
Besse, Benjamin [1 ]
机构：
[1] Inst Gustave Roussy, Villejuif, France
来源：
CANCER RESEARCH | 2012年 / 72卷
关键词：
D O I：
10.1158/1538-7445.AM2012-1715
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
1715
引用
收藏
页数：1
相关论文
共 50 条
  • [1] HIGH ALK GENE COPY NUMBER IS A FREQUENT EVENT IN NON-SMALL CELL TUMORS AND CELL LINES OF LUNG CANCER
    Kalai, Khadija
    Auger, Nathalie
    Lacroix, Ludovic
    Dorvault, Nicolas
    Olaussen, Ken
    Valent, Alexander
    Planchard, David
    Soria, Jean Charles
    Besse, Benjamin
    JOURNAL OF THORACIC ONCOLOGY, 2011, 6 (06) : S1081 - S1081
  • [2] High ALK Gene Copy Number in Non-small Cell Advanced Lung Cancers
    Kalai, K.
    Auger, N.
    Lacroix, L.
    Dorvault, N.
    Olaussen, K.
    Valent, A.
    Rajpar, S.
    Planchard, D.
    Besse, B.
    EUROPEAN JOURNAL OF CANCER, 2011, 47 : S611 - S611
  • [3] ALK COPY NUMBER CHANGES IN NON-SMALL CELL LUNG CANCER
    Arriola, Edurne
    Taus, Alvaro
    Salido, Marta
    Galvan, Ana B.
    Martinez-Aviles, Luz
    Gimeno, Javier
    Serrano, Sergio
    Bellosillo, Beatriz
    Sole, Francesc
    Albanell, Joan
    JOURNAL OF THORACIC ONCOLOGY, 2011, 6 (06) : S507 - S508
  • [4] Increased ALK Gene Copy Number and Amplification are Frequent in Non-small Cell Lung Cancer
    Salido, Marta
    Pijuan, Lara
    Martinez-Aviles, Luz
    Galvan, Ana B.
    Canadas, Israel
    Rovira, Ana
    Zanui, Montserrat
    Martinez, Alejandro
    Longaron, Raquel
    Sole, Francisco
    Serrano, Sergio
    Bellosillo, Beatriz
    Wynes, Murry W.
    Albanell, Joan
    Hirsch, Fred R.
    Arriola, Edurne
    JOURNAL OF THORACIC ONCOLOGY, 2011, 6 (01) : 21 - 27
  • [5] COPY NUMBER ABBERATION IN NON-SMALL CELL LUNG CANCER WITH ALK FUSION PROTEIN
    Yokoi, Sana
    Kimura, Hideki
    Kageyama, Hajime
    Iizasa, Toshihiko
    Ohira, Miki
    Nagase, Hiroki
    Nakagawara, Akira
    JOURNAL OF THORACIC ONCOLOGY, 2011, 6 (06) : S971 - S971
  • [6] ALK amplification and crizotinib sensitivity in non-small cell lung cancer cell lines and patients report.
    Khadija, Kalai
    Auger, Nathalie
    Lueza, Beranger
    Commo, Frederic
    Valent, Alexander
    Rousseau, Vanessa
    Dorvault, Nicolas
    Friboulet, Luc
    Olaussen, Ken
    Rajpar, Laetitia
    Planchard, David
    Lacroix, Ludovic
    Pignon, Jean-Pierre
    Soria, Jean-Charles
    Besse, Benjamin
    JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (15)
  • [7] Mechanisms of Resistance to Crizotinib in Patients with ALK Gene Rearranged Non-Small Cell Lung Cancer
    Doebele, Robert C.
    Pilling, Amanda B.
    Aisner, Dara L.
    Kutateladze, Tatiana G.
    Le, Anh T.
    Weickhardt, Andrew J.
    Kondo, Kimi L.
    Linderman, Derek J.
    Heasley, Lynn E.
    Franklin, Wilbur A.
    Varella-Garcia, Marileila
    Camidge, D. Ross
    CLINICAL CANCER RESEARCH, 2012, 18 (05) : 1472 - 1482
  • [8] Percentage of ALK Rearrangement as a Response Predictor in Non-Small Cell Lung Cancer Treatment
    Oliveira, M.
    Natal, R.
    Costa, J.
    Gomes, R.
    Amaral, A.
    Ferreira, L.
    JOURNAL OF THORACIC ONCOLOGY, 2019, 14 (10) : S1076 - S1077
  • [9] Crizotinib for ALK rearrangement in non small cell lung cancer
    Merrick, S. A.
    Hunter, S.
    Dalby, M.
    Neat, M.
    McMunagle, E.
    Montes, A.
    Lal, R.
    Ghosh, S.
    LUNG CANCER, 2017, 103 : S29 - S30
  • [10] Variants on a Theme: A Biomarker of Crizotinib Response in ALK-Positive Non-Small Cell Lung Cancer?
    Crystal, Adam S.
    Shaw, Alice T.
    CLINICAL CANCER RESEARCH, 2012, 18 (17) : 4479 - 4481
12345